Immunogenicity & Pharmacokinetic Assays for the Detection of Biologics and Biosimilars

Log in or register to read this article in full and gain access to The Medicine Maker’s entire content archive. It’s FREE!

Email*

Choose a password*

I have read and understand the Privacy Notice *

Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

I want to stay up to date with the "Small Molecule" field I want to stay up to date with the Cell and Gene field I want to stay up to date with the Bioprocessing field

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

Address: BioGenes GmbH, Koepenicker Str. 325, 12555 Berlin.

Phone: +49 30 65762396

Email: [email protected]

Visit Website

BioGenes provides customized immunoassays and antibodies, with a strong commitment to quality and service. Founded in 1992 and headquartered in Berlin, Germany, BioGenes is a recognized partner serving more than 600 customers worldwide. The company maintains long-term relationships with pharmaceutical and biotech companies, CMOs, CROs and diagnostic firms. BioGenes provides customized solutions for biological products, from drug discovery and drug development to the manufacturing and quality control of biologicals. The company specializes in sophisticated custom monoclonal, polyclonal and anti-idiotypic antibody development and has a proven track record in the development, optimization, pre-validation and production of highly sensitive and robust ELISAs.

Beyond "Disease X": Strategic R&D in an Era of Emerging Threats

10/30/2024 | Sponsored by Biosynth